ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 219 filers reported holding ICU MED INC in Q1 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,084,756 | +17.2% | 42,819 | +5.9% | 0.00% | 0.0% |
| Q1 2024 | $4,337,767 | +7.6% | 40,419 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $4,031,391 | -24.8% | 40,419 | -10.2% | 0.00% | -25.0% |
| Q3 2023 | $5,357,711 | -32.5% | 45,019 | +1.1% | 0.00% | -20.0% |
| Q2 2023 | $7,932,841 | +9.2% | 44,519 | +1.1% | 0.01% | 0.0% |
| Q1 2023 | $7,261,374 | -5.9% | 44,019 | -10.2% | 0.01% | -16.7% |
| Q4 2022 | $7,719,512 | +6.5% | 49,019 | +1.9% | 0.01% | +20.0% |
| Q3 2022 | $7,247,000 | -7.6% | 48,119 | +0.8% | 0.01% | 0.0% |
| Q2 2022 | $7,845,000 | -26.2% | 47,719 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $10,624,000 | +1.0% | 47,719 | +7.7% | 0.01% | 0.0% |
| Q4 2021 | $10,519,000 | +1.2% | 44,319 | -0.4% | 0.01% | -14.3% |
| Q3 2021 | $10,390,000 | +14.4% | 44,519 | +0.9% | 0.01% | +16.7% |
| Q2 2021 | $9,080,000 | -2.9% | 44,119 | -3.1% | 0.01% | 0.0% |
| Q1 2021 | $9,351,000 | -3.2% | 45,519 | +1.1% | 0.01% | -14.3% |
| Q4 2020 | $9,656,000 | +17.9% | 45,019 | +0.4% | 0.01% | +16.7% |
| Q3 2020 | $8,191,000 | +1.2% | 44,819 | +2.0% | 0.01% | -14.3% |
| Q2 2020 | $8,095,000 | +5.3% | 43,919 | +15.2% | 0.01% | -12.5% |
| Q1 2020 | $7,691,000 | +9.3% | 38,119 | +1.3% | 0.01% | +14.3% |
| Q4 2019 | $7,039,000 | +19.8% | 37,619 | +2.2% | 0.01% | +16.7% |
| Q3 2019 | $5,876,000 | -35.6% | 36,819 | +1.7% | 0.01% | -40.0% |
| Q2 2019 | $9,124,000 | +27.8% | 36,219 | +21.5% | 0.01% | +25.0% |
| Q1 2019 | $7,137,000 | +7.5% | 29,819 | +3.1% | 0.01% | -11.1% |
| Q4 2018 | $6,641,000 | -17.1% | 28,919 | +2.1% | 0.01% | 0.0% |
| Q3 2018 | $8,007,000 | -3.7% | 28,319 | 0.0% | 0.01% | -10.0% |
| Q2 2018 | $8,316,000 | +18.4% | 28,319 | +1.8% | 0.01% | +11.1% |
| Q1 2018 | $7,022,000 | +19.4% | 27,819 | +2.2% | 0.01% | +50.0% |
| Q4 2017 | $5,879,000 | +21.1% | 27,219 | +4.2% | 0.01% | 0.0% |
| Q3 2017 | $4,854,000 | +7.7% | 26,119 | 0.0% | 0.01% | +20.0% |
| Q2 2017 | $4,506,000 | +15.2% | 26,119 | +2.0% | 0.01% | 0.0% |
| Q1 2017 | $3,912,000 | +7.4% | 25,619 | +3.6% | 0.01% | -16.7% |
| Q4 2016 | $3,642,000 | +16.6% | 24,719 | 0.0% | 0.01% | +20.0% |
| Q3 2016 | $3,124,000 | +11.2% | 24,719 | -0.8% | 0.01% | 0.0% |
| Q2 2016 | $2,810,000 | +18.4% | 24,919 | +5.5% | 0.01% | +25.0% |
| Q1 2016 | $2,373,000 | +13.0% | 23,619 | +26.9% | 0.00% | -20.0% |
| Q4 2015 | $2,100,000 | +3.0% | 18,619 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $2,039,000 | +44.0% | 18,619 | +25.8% | 0.01% | +25.0% |
| Q2 2015 | $1,416,000 | +7.8% | 14,800 | +5.0% | 0.00% | 0.0% |
| Q1 2015 | $1,313,000 | +13.7% | 14,100 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,155,000 | +31.4% | 14,100 | +2.9% | 0.00% | +33.3% |
| Q3 2014 | $879,000 | +5.5% | 13,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $833,000 | +1.6% | 13,700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $820,000 | +26.2% | 13,700 | +34.3% | 0.00% | 0.0% |
| Q4 2013 | $650,000 | -6.2% | 10,200 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $693,000 | -10.9% | 10,200 | -5.6% | 0.00% | 0.0% |
| Q2 2013 | $778,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
| CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
| PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
| Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
| GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
| Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
| Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
| PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
| DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
| GAM Holding AG | 90,452 | $20,769,000 | 1.05% |